Scholarlink

Purpose <p>Kidney injury molecule-1 (KIM-1) is a transmembrane glycoprotein expressed in injured proximal tubules and renal cell carcinoma (RCC). This study evaluated urinary (uKIM-1) and plasma (pKIM-1) concentrations in patients with clear cell RCC (ccRCC) as potential diagnostic and prognostic biomarkers.</p> Methods <p>A prospective observational study included 73 patients undergoing nephrectomy for renal tumors and 34 healthy volunteers. KIM-1 levels were measured using ELISA and analyzed in relation to tumor size, TNM stage, WHO/ISUP grade, and histopathological features. Diagnostic performance was assessed using ROC curves. Correlations were evaluated using Spearman coefficients.</p> Results <p>Both uKIM-1 and pKIM-1 levels were significantly higher in ccRCC patients compared to those with non-ccRCC tumors and healthy individuals (<i>p</i> &lt; 0.001). pKIM-1 &gt; 75 pg/ml demonstrated high diagnostic performance for ccRCC (AUC = 0.93, sensitivity = 90.4%, specificity = 94.1%). uKIM-1 &gt; 1.15 ng/mg uCr showed lower performance (AUC = 0.78, sensitivity = 69%, specificity = 73.5%). Biomarker levels correlated positively with tumor size (<i>R</i> = 0.66), TNM stage (<i>R</i> = 0.61), and histological grade (<i>R</i> = 0.58). Both markers were elevated in tumors with necrosis and perirenal fat invasion.</p> Conclusion <p>KIM-1 is a promising non-invasive biomarker for ccRCC. Plasma KIM-1 &gt; 75 pg/ml distinguishes ccRCC from healthy individuals with high sensitivity and specificity, while also correlating with tumor aggressiveness. Its measurement may support diagnosis, risk stratification, and follow-up in ccRCC patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diagnostic utility of plasma and urine KIM-1 levels in clear cell renal cell carcinoma: an observational prospective study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月29日

查看全文
  • Krzysztof Ratajczyk,
  • Karolina Marek-Bukowiec,
  • Jakub Karwacki,
  • Paweł Kowal,
  • Michał Pietrus,
  • Marek Fiutowski,
  • Wojciech Witkiewicz,
  • Mikołaj Kisiała,
  • Tomasz Szydełko,
  • Bartosz Małkiewicz,
  • Anna Kołodziej

摘要

Purpose

Kidney injury molecule-1 (KIM-1) is a transmembrane glycoprotein expressed in injured proximal tubules and renal cell carcinoma (RCC). This study evaluated urinary (uKIM-1) and plasma (pKIM-1) concentrations in patients with clear cell RCC (ccRCC) as potential diagnostic and prognostic biomarkers.

Methods

A prospective observational study included 73 patients undergoing nephrectomy for renal tumors and 34 healthy volunteers. KIM-1 levels were measured using ELISA and analyzed in relation to tumor size, TNM stage, WHO/ISUP grade, and histopathological features. Diagnostic performance was assessed using ROC curves. Correlations were evaluated using Spearman coefficients.

Results

Both uKIM-1 and pKIM-1 levels were significantly higher in ccRCC patients compared to those with non-ccRCC tumors and healthy individuals (p < 0.001). pKIM-1 > 75 pg/ml demonstrated high diagnostic performance for ccRCC (AUC = 0.93, sensitivity = 90.4%, specificity = 94.1%). uKIM-1 > 1.15 ng/mg uCr showed lower performance (AUC = 0.78, sensitivity = 69%, specificity = 73.5%). Biomarker levels correlated positively with tumor size (R = 0.66), TNM stage (R = 0.61), and histological grade (R = 0.58). Both markers were elevated in tumors with necrosis and perirenal fat invasion.

Conclusion

KIM-1 is a promising non-invasive biomarker for ccRCC. Plasma KIM-1 > 75 pg/ml distinguishes ccRCC from healthy individuals with high sensitivity and specificity, while also correlating with tumor aggressiveness. Its measurement may support diagnosis, risk stratification, and follow-up in ccRCC patients.